Financhill
Back

Recursion Pharmaceuticals Stock Price Chart

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RXRX is experiencing slight selling pressure.

Recursion Pharmaceuticals Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 5.19 Buy
20-day SMA: 5.13 Buy
50-day SMA: 4.89 Buy
200-day SMA: 6.3 Sell
8-day EMA: 5.16 Buy
20-day EMA: 5.06 Buy
50-day EMA: 5.1 Buy
200-day EMA: 6.21 Sell

Recursion Pharmaceuticals Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.1 Buy
Relative Strength Index (14 RSI): 55.16 Buy
Chaikin Money Flow: 5527369 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

Recursion Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Recursion Pharmaceuticals Stock

Is Recursion Pharmaceuticals Stock a Buy?

RXRX Technical Analysis vs Fundamental Analysis

Sell
49
Recursion Pharmaceuticals (RXRX) is a Sell

Is Recursion Pharmaceuticals a Buy or a Sell?

Recursion Pharmaceuticals Stock Info

Market Cap:
2.1B
Price in USD:
5.27
Share Volume:
16.6M

Recursion Pharmaceuticals 52-Week Range

52-Week High:
12.36
52-Week Low:
3.79
Sell
49
Recursion Pharmaceuticals (RXRX) is a Sell

Recursion Pharmaceuticals Share Price Forecast

Is Recursion Pharmaceuticals Stock a Buy?

Fundamental Analysis of Recursion Pharmaceuticals

Is Recursion Pharmaceuticals a good investment?

  • Analysts estimate an earnings increase this quarter of $0.18 per share, an increase next quarter of $0.23 per share, an increase this year of $0.08 per share, and an increase next year of $0.31 per share.

Technical Analysis of Recursion Pharmaceuticals

Should I short Recursion Pharmaceuticals stock?

* Recursion Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.